NCT00639587View on ClinicalTrials.gov

Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL

Enrollment

149

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG

Ketotifen

Ketotifen dry syrup 0.1%; 1 mg b.i.d.; for 2 weeks

DRUG

Cetirizine

Cetirizine tablet; 10 mg o.d.; for 2 weeks and 5 mg b.i.d.; for 2 weeks

Sponsors

Lead Sponsor

All Listed Sponsors

lead

UCB Pharma

INDUSTRY

NCT00639587 - Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis | Biotech Hunter | Biotech Hunter